Scientific Publications

Search by Keyword(s)
Found 3 results

Filters: Author is Wadleigh, M  [Clear All Filters]

Search Results

  • Showing 1-3 of 3 Results
2013
A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia.DeAngelo, DJ, Neuberg D., Amrein PC, Berchuck J., Wadleigh M., Sirulnik LA, Galinsky I., Golub T., Stegmaier K., and Stone RM Leukemia research, 2013/11/05, (2013) Read More / View Supplemental Materials
Abstract
2006
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.Pikman, Y., Lee BH, Mercher T., McDowell E., Ebert BL, Gozo M., Cuker A., Wernig G., Moore S., Galinsky I., DeAngelo DJ, Clark JJ, Lee SJ, Golub T. R., Wadleigh M., Gilliland DG, and Levine RL PLoS medicine, 2006/07/01, Volume 3, Issue 7, p.e270, (2006) Read More / View Supplemental Materials
Abstract
2005
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.Levine, RL, Wadleigh M., Cools J., Ebert BL, Wernig G., Huntly BJ, Boggon TJ, Wlodarska I., Clark JJ, Moore S., Adelsperger J., Koo S., Lee JC, Gabriel S., Mercher T., D'Andrea A., Fröhling S., Döhner K., Marynen P., Vandenberghe P., et al. Cancer cell, 2005/04/01, Volume 7, Issue 4, p.387-97, (2005) Read More / View Supplemental Materials
Abstract
  • Showing 1-3 of 3 Results